India is pushing for greater local production capacity and movement up the value chain in its medical device industry by improving incentives, regulation.
India is keen to review its FTA with ASEAN to ensure fair and reciprocal market access and address concerns over misuse of the application of rules of origin.
Financial, legal, tax, and HR due diligence will enable foreign companies evaluate every aspect of their potential business undertaking in India.
Tax scrutiny is set to change in India as the assessment process will no longer be jurisdiction based in most cases.
We briefly profile the key segments open to foreign investors in India’s healthcare industry, including hospitals and medical tourism, diagnostics, and health insurance.
COVID-19 is reshaping India’s healthcare landscape with various segments, including telehealth, nutrition, and hygiene primed for innovation and investment.
In India, industrial licensing norms are mandatory for only selected industries.
We explain how India’s FDI policy change will impact the approval route for investments from China.